Clinical Conversation: SCAI Position Statement on Transcatheter Occlusion of Patent Ductus Arteriosus in Premature Infants

Description

This conversation discusses the JSCAI article, "SCAI Position Statement on Transcatheter Occlusion of Patent Ductus Arteriosus in Premature Infants."

Transcatheter occlusion of patent ductus arteriosus (PDA) in premature infants is a minimally invasive procedure used to close a persistent fetal blood vessel that can lead to serious complications if left untreated. This approach has shown high success rates and is increasingly favored over surgical ligation due to its lower invasiveness and reduced risk of post-ligation syndrome. The procedure is typically considered when medical therapy fails or is contraindicated, especially in infants with hemodynamically significant PDA.

Faculty

	Frank F. Ing, MD, MSCAI Moderator		Brent M. Gordon, MD, FSCAI Presenting Author
	Carl Backes, MD Panelist		Sarosh P. Batlivala, MD, FSCAI Panelist
	Stephen Nageotte, MD, MBA, FSCAI Panelist		Evan M. Zahn, MD, MSCAI Panelist

Learning Objectives

Upon completion of this activity, participants will be able to:

Evaluate factors for selecting premature infants for transcatheter PDA occlusion, including considerations of respiratory support, pulmonary over-circulation, and clinical signs of systemic hypoperfusion.
Apply optimal procedural and technical considerations for transcatheter PDA occlusion, including pre-procedure planning, procedural techniques, and management of potential complications.
Describe the recommended training and competency standards for physicians performing transcatheter PDA occlusion in premature infants, including specific skill sets and procedural volume requirements.
Understand the necessary institutional infrastructure, multidisciplinary team coordination, and regional network development to support successful transcatheter PDA occlusion programs for premature infants.

Acknowledgement of Commercial Support

This activity is supported by unrestricted educational grants from Abbott and Merit Medical.

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Read the article and complete the post test to obtain credit.

Activity Timeline
Recording date: 12/18/2025
Publish date: 1/27/2026
Expiration date: 1/27/2029

Summary

Availability:

On-Demand

Access expires on Jan 27, 2029

Cost:

FREE

Credit Offered:

0.5 CME Credit

0.5 ABP-MOC Point

0.5 Participation Credit